← Alle mensen

SA

S Atagi

2 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Veiligheid en PROs van atezolizumab-chemo bij uitgebreid SCLC: IMpower133 analyse

Annals of oncology : official journal of the European Society for Medical Oncology · 2020-02

Gefitinib versus cisplatine-docetaxel bij EGFR-gemuteerd NSCLC: WJTOG3405 definitieve OS

Annals of oncology : official journal of the European Society for Medical Oncology · 1 december 2019